MedPath

Surgical Management of Complex Intracranial Aneurysms With Hybrid Operating Techniques

Not Applicable
Conditions
Intracranial Aneurysm
Interventions
Procedure: Hybrid Operating Techniques
Registration Number
NCT03206853
Lead Sponsor
liuxingju
Brief Summary

To evaluate the clinical benefits and risks of hybrid operating techniques in management of complex intracranial aneurysms, which could coexists with multiple risk factors.

Detailed Description

Purpose: Have an evaluation of clinical benefits and risks of hybrid operating techniques in management of complex intracranial aneurysms (CIAs), which could coexists with multiple risk factors. Meanwhile, as a new cooperative interventional modality, optimized workflows, technical key knots and operation routines will be explored in the study.

Objects: Patients with CIAs, coincident with inclusion and exclusion criterion and admitted in participating organizations.

Methods: Patients will be distributed into 2 groups, including traditional therapy group(control group) and hybrid operating group(trial group), and conduct with traditional neurosurgical management or one-stage hybrid operating management correspondingly. Peri-operative mortality rate is considered to be the primary observing indicator, and morbidity rate of peri-operative cerebral hemorrhagic/ischemic event, morbidity rate of aneurysmal residuals, morbidity rate of neural functional deteriorations, and health-economic indicators are secondary indicators.The information of operations will be recorded in detail as evidence of optimization of workflow and technical key knots.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
258
Inclusion Criteria
  • with diagnosed complex intracranial aneurysm by digital subtraction angiography(DSA);
  • got SAH in history;
  • neural functional deficits due to aneurysms;
  • with <4 in Hunt-Hess Grades;
  • ≥5.0mm in the maximum diameter;
  • <70 years old;
  • with irregular morphological features and high rupture risk.
Exclusion Criteria
  • >70 in age, with low rupture risk;
  • cannot tolerant the operation;
  • patient or relative refuses to participate the trail;
  • SAH patient with ≥4 Hunt-Hess grading system;
  • <5.0mm in the maximum diameter.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Traditional therapy groupHybrid Operating TechniquesThe aneurysms will be executed by traditional procedure, including microsurgical clipping, endovascular coiling or stenting, etc.
Hybrid operation groupHybrid Operating TechniquesIntervene with hybrid operating techniques, eg. microsurgical clipping+endovascular coiling or with the assistant of balloon occlusion.
Primary Outcome Measures
NameTimeMethod
operation-related mortality rateFrom the time of operation begin to 48 hours after operation

the mortality rate related to the operation

Secondary Outcome Measures
NameTimeMethod
Morbidity rate of peri-operative intracranial ischemic eventsFrom date of admission to 7 days after operation

The intracranial ischemic events happening during the peri-operative period, including operation-related infarction, embolization, etc. With neuro-imaging evidence.

Residual rate of aneurysmsthe date of first post-operative cerebrovascular angiography is conducted, up to 3 months after operation

the morbidity rate of aneurysmal residue, with post-operative DSA/CTA evidence

Morbidity rate of neural functional deterioration in 48 hours after operation48 hours after operation, ±6 hours

The score of modified Rankin Scale increases ≥2, comparing to the original mRS scores

Duration of total operating timethrough study completion, an average of 1 year

Total operating time of all procedures, including operation, and DSA

Morbidity rate of peri-operative intracranial hemorrhageFrom date of admission to the 7 days after operation

Intracranial hemorrhagic events happening during the peri-operative period, including subarachnoid hemorrhage, intracranial hemorrhage, intraventricular hemorrhage caused by the rupture of aneurysms with neuro-imaging evidence.

Morbidity rate of neural functional deterioration in 12 monthsthe 12th month after operation, ±1 week

The score of modified Rankin Scale increases ≥2, comparing to the original mRS scores

Treatment-related coststhrough study completion, an average of 1 year

All expenses cost in hospital relating to the aiming disease

Duration of hospitalizationthrough study completion, an average of 1 year

Total hospitalization of all stages of treatments to IAs, including admissions for evaluation, operation, and DSA

Morbidity rate of neural functional deterioration in 7 days7 days after operation, ±2 days

The score of modified Rankin Scale increases ≥2, comparing to the original mRS scores

Morbidity rate of neural functional deterioration in 3 monthsthe 3rd month after operation, ±1 week

The score of modified Rankin Scale increases ≥2, comparing to the original mRS scores

Morbidity rate of neural functional deterioration in 6 monthsthe 6th month after operation, ±1 week

The score of modified Rankin Scale increases ≥2, comparing to the original mRS scores

Trial Locations

Locations (1)

Beijing Tiantan Hospital Capital Medical University

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath